Unknown

Dataset Information

Biosecurity risks associated with vaccine platform technologies.


ABSTRACT: Vaccine platforms have been critical for accelerating the timeline of COVID-19 vaccine development. Faster vaccine timelines demand further development of these technologies. Currently investigated platform approaches include virally vectored and RNA-based vaccines, as well as DNA vaccines and recombinant protein expression system platforms, each featuring different advantages and challenges. Viral vector-based and DNA vaccines in particular have received a large share of research funding to date. Platform vaccine technologies may feature dual-use potential through informing or enabling pathogen engineering, which may raise the risk for the occurrence of deliberate, anthropogenic biological events. Research on virally vectored vaccines exhibits relatively high dual-use potential for two re

SUBMITTER: Sandbrink JB 

PROVIDER: S-EPMC7904460 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature